A Phase II Study on Adjuvant Vaccination with Dendritic Cells Loaded with Autologous Tumor Homogenate in Resected Stage IV Rare Cancers.

Clinical trial NCT04166006 · RECRUITING

Trial details

NCT number: NCT04166006
Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Head Neck Tumors Neuroendocrine Tumors Soft Tissue Sarcoma Rare Cancer Vaccination

Start date: 2019-12-12
Primary completion: 2027-04-01
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.